$0.739000
0.023.15%
At close: -
$0.752200
0.011.79%
After Hours: 7:35 AM EDT
Cyclo Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Cyclo Therapeutics using advanced sorting and filters.
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Jun 2024 | 2024-08-14 | $-0.21 | $-0.15 | -40.0 % |
Jun 2023 | 2023-08-14 | $-0.33 | $-0.44 | 25.0 % |
Mar 2023 | 2023-05-15 | $-0.46 | $-0.42 | -9.52 % |
Dec 2022 | 2023-03-20 | $-0.59 | $-0.25 | -136.0 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Jun 2024 | 2024-08-14 | $123.10K | $270.00K | -54.4 % |
Sep 2023 | 2023-11-14 | $459.48K | $430.00K | 6.86 % |
Jun 2023 | 2023-08-14 | $117.12K | $400.00K | -70.7 % |
Mar 2023 | 2023-05-15 | $152.41K | $380.00K | -59.9 % |
Cyclo Therapeutics (CYTH) is scheduled to report earnings on November 19, 2024. The last reported earnings were for reported on August 14, 2024 for Q2.
The Actual EPS was $-0.21, which missed the estimate of $-0.15.
The Actual Revenue was $123.1K, which missed the estimate of $270K.
Browse earnings estimates, EPS, and revenue on all stocks.